Evidence map›Paper›PMID 22916036›Full record

ArticlePLoS genetics2012

Stromal liver kinase B1 [STK11] signaling loss induces oviductal adenomas and endometrial cancer by activating mammalian Target of Rapamycin Complex 1.

Pradeep S Tanwar, Tomoko Kaneko-Tarui, Lihua Zhang, Yoshihiro Tanaka, Christopher P Crum, Jose M Teixeira

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. Article
  3. Loss of liver kinase B1 in human seminoma.Frontiers in oncology · 2023
    Article
  4. Bovine and human endometrium-derived hydrogels support organoid culture from healthy and cancerous tissues.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. OncogenicmicroPublication biology · 2020
    Article
  7. The Effect of LKB1 Activity on the Sensitivity to PI3K/mTOR Inhibition in Non-Small Cell Lung Cancer.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2019
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Specific deletion of LKB1/Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  15. Article
  16. Article
  17. Article
  18. PI3K/Akt/mTOR signaling & its regulator tumour suppressor genesThe Indian journal of medical research · 2016
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Pradeep S TanwarVincent Center for Reproductive Biology, Department of Obstetrics, Gynecology, and Reproductive Biology, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Tomoko Kaneko-Tarui
Lihua Zhang
Yoshihiro Tanaka
Christopher P Crum
Jose M Teixeira
Reproductive Science Center · USMassachusetts General Hospital · USBrigham and Women's Hospital · US

Funding

Beta-catenin biology in regeneration of uterine smooth muscleR01HD052701 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI TEIXEIRA, JOSE M. · 2008 to 2012
$1.6M
NICHD NIH HHS HD052701NICHD NIH HHS R01 HD052701
6 · The paper itself

Abstract

Germline mutations of the Liver Kinase b1 (LKB1/STK11) tumor suppressor gene have been linked to Peutz-Jeghers Syndrome (PJS), an autosomal-dominant, cancer-prone disorder in which patients develop neoplasms in several organs, including the oviduct, ovary, and cervix. We have conditionally deleted Lkb1 in Müllerian duct mesenchyme-derived cells of the female reproductive tract and observed expansion of the stromal compartment and hyperplasia and/or neoplasia of adjacent epithelial cells throughout the reproductive tract with paratubal cysts and adenomyomas in oviducts and, eventually, endometrial cancer. Examination of the proliferation marker phospho-histone H3 and mammalian Target Of Rapamycin Complex 1 (mTORC1) pathway members revealed increased proliferation and mTORC1 activation in stromal cells of both the oviduct and uterus. Treatment with rapamycin, an inhibitor of mTORC1 activity, decreased tumor burden in adult Lkb1 mutant mice. Deletion of the genes for Tuberous Sclerosis 1 (Tsc1) or Tsc2, regulators of mTORC1 that are downstream of LKB1 signaling, in the oviductal and uterine stroma phenocopies some of the defects observed in Lkb1 mutant mice, confirming that dysregulated mTORC1 activation in the Lkb1-deleted stroma contributes to the phenotype. Loss of PTEN, an upstream regulator of mTORC1 signaling, along with Lkb1 deletion significantly increased tumor burden in uteri and induced tumorigenesis in the cervix and vagina. These studies show that LKB1/TSC1/TSC2/mTORC1 signaling in mesenchymal cells is important for the maintenance of epithelial integrity and suppression of carcinogenesis in adjacent epithelial cells. Because similar changes in the stromal population are also observed in human oviductal/ovarian adenoma and endometrial adenocarcinoma patients, we predict that dysregulated mTORC1 activity by upstream mechanisms similar to those described in these model systems contributes to the pathogenesis of these human diseases.

Indexed as

AdenomaAMP-Activated Protein KinasesAnimalsCervix UteriDisease Models, AnimalEndometrial NeoplasmsEndometriumFemaleGene DeletionGene Expression Regulation, NeoplasticHumansMechanistic Target of Rapamycin Complex 1Mesenchymal Stem CellsMiceMultiprotein ComplexesOvaryAMP-Activated Protein KinasesMechanistic Target of Rapamycin Complex 1Multiprotein ComplexesProteinsProtein Serine-Threonine KinasesPTEN PhosphohydrolasePten protein, mouseSirolimusStk11 protein, mouseTOR Serine-Threonine KinasesTSC1 protein, humanTsc1 protein, mouseTSC2 protein, humanTsc2 protein, mouseTuberous Sclerosis Complex 1 ProteinTuberous Sclerosis Complex 2 ProteinTumor Suppressor Proteins

Identifiers

PMID22916036
PMCPMC3420942
OpenAlexW2109709201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.